Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) is targeting a potential breakthrough treatment for patients with problematic scar tissue to service unmet demand and a...
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) is targeting a potential breakthrough treatment for patients with problematic scar tissue to service unmet demand and a...
Cystic Fibrosis Therapeutics Market Is Expected To Reach $9,277.3 Million By 2026, Registering a CAGR of 9.2%
Cystic Fibrosis Therapeutics Market Is Expected To Reach $9,277.3 Million By 2026, Registering a CAGR of 9.2%
“Together, our work aims to support commercialisation of new treatment approaches for pancreatic cancer and various skin diseases, which we...